Literature DB >> 3291922

Loss of polymorphic A and B locus HLA antigens in colon carcinoma.

R C Rees1, A M Buckle, K Gelsthorpe, V James, C W Potter, K Rogers, G Jacob.   

Abstract

In the present study we have confirmed that approximately one third of human colorectal carcinomas fail to express the HLA - A,B,C monomorphic determinant reactive with the W6/32 MAb, and 44% express class II HLA antigens as shown by reactivity with NFK-1 MAb. Reduced staining with the W6/32 MAb was not always associated with the loss of beta 2m. In addition, the expression of HLA-A2 and Bw4 class I specific haplotypes on normal colon epithelium and tumour biopsy tissue was assessed. All normal colonic epithelia stained positively with MAb against A2 and Bw4 antigens, but a loss of these determinants was shown on tumour biopsies from patients tissue typed for the respective specificities. Loss of the A2 haplotype was shown in 4 of 15 tumour tissue samples, and loss of Bw4 specificities in 5 out of 7 tissue samples. The failure to detect specific loci determinants was not necessarily associated with loss of reactivity with W6/32 MAb.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3291922      PMCID: PMC2246567          DOI: 10.1038/bjc.1988.85

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

Review 1.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Anomolous expression of HLA-DR antigens on human colorectal cancer cells.

Authors:  A S Daar; S V Fuggle; A Ting; J W Fabre
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

3.  Tissue Typing of cultured human tumor cell lines: the detection of genetically appropriate HLA-A, B, C, and DR alloantigens.

Authors:  M S Pollack; S Heagney; J Fogh
Journal:  Transplant Proc       Date:  1980-03       Impact factor: 1.066

4.  Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer.

Authors:  A K Bhan; C L DesMarais
Journal:  J Natl Cancer Inst       Date:  1983-09       Impact factor: 13.506

5.  The membrane antigens of human colorectal cancer cells: demonstration with monoclonal antibodies of heterogeneity within and between tumours and of anomalous expression of HLA-DR.

Authors:  A S Daar; J W Fabre
Journal:  Eur J Cancer Clin Oncol       Date:  1983-02

6.  Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells.

Authors:  P G Natali; P Giacomini; A Bigotti; K Imai; M R Nicotra; A K Ng; S Ferrone
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

7.  Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer.

Authors:  K A Fleming; A McMichael; J A Morton; J Woods; J O McGee
Journal:  J Clin Pathol       Date:  1981-07       Impact factor: 3.411

8.  Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens.

Authors:  D J Rowe; P C Beverley
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

9.  Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease.

Authors:  H L Whitwell; H P Hughes; M Moore; A Ahmed
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

10.  Is heterogeneous expression of HLA-dr antigens and CEA along with DNA-profile variations evidence of phenotypic instability and clonal proliferation in human large bowel carcinomas?

Authors:  T O Rognum; P Brandtzaeg; E Thorud
Journal:  Br J Cancer       Date:  1983-10       Impact factor: 7.640

View more
  12 in total

1.  Selective changes in expression of HLA class I polymorphic determinants in human solid tumors.

Authors:  P G Natali; M R Nicotra; A Bigotti; I Venturo; L Marcenaro; P Giacomini; C Russo
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

2.  Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia.

Authors:  M E Smith; S G Marsh; J G Bodmer; K Gelsthorpe; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

3.  Application of isoelectric focusing for studies of major histocompatibility complex class I antigen expression on human carcinomas and sarcomas.

Authors:  P Wang; F Vánky; E Klein
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

4.  Expression of MHC class I and class II antigens in primary breast carcinomas and synchronous nodal metastases.

Authors:  A Maiorana; A M Cesinaro; R A Fano; G Collina
Journal:  Clin Exp Metastasis       Date:  1995-01       Impact factor: 5.150

5.  Lymphocyte subset infiltration patterns and HLA antigen status in colorectal carcinomas and adenomas.

Authors:  P A Jackson; M A Green; C G Marks; R J King; R Hubbard; M G Cook
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

6.  Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma.

Authors:  A M Nouri; M E Smith; D Crosby; R T Oliver
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

7.  Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.

Authors:  H O Wintzer; M Benzing; S von Kleist
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

8.  Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma.

Authors:  J R Goepel; R C Rees; K Rogers; C J Stoddard; W E Thomas; L Shepherd
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

Review 9.  HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy.

Authors:  Per Anderson; Natalia Aptsiauri; Francisco Ruiz-Cabello; Federico Garrido
Journal:  Cell Mol Immunol       Date:  2021-01-20       Impact factor: 22.096

10.  KBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells.

Authors:  D Plaksin; P A Baeuerle; L Eisenbach
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.